Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Budesonide for Early COVID-19
NCT04416399Phase 2Terminated
- Sponsor
- University of Oxford
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in coronavirus disease 2019 (COVID-19), sponsored by University of Oxford. Started Jul 2020; status: terminated.
02
Drugs
budesonide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04416399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04416399.